5/7/2025Innovent Presents Positive Phase 2 Data for First-in-Class Bispecific ...

5/6/2025Immunochina’s IM96 CAR-T Cell Therapy Wins FDA IND Clearance

5/6/2025China Approves Six Novel Drugs in April 2025, Marking Significant Adva...

5/6/2025Kintor Reports Superior Hair Regrowth Results for KX-826 and Minoxidil...

5/6/2025CStone Unveils Promising Preclinical Data for Trispecific Antibody CS2...

5/6/2025China Seeks Feedbacks on Draft Guideline for Risk Management Plan Duri...

5/6/2025China Seeks Feedbacks on ICH Q1 Stability Testing Guideline Draft

5/6/2025China Announces Ambitious Plan to Optimize Primary Healthcare System b...

5/2/2025Recent Executive Moves

5/1/2025D3 Bio Showcases Promising Next-Gen KRAS G12C Inhibitor at AACR and in...

5/1/2025China Accelerates Investment in Africa's Burgeoning Pharma Sector

5/1/2025CSL Reviews Potential China Tariff Relief for U.S.-Produced Albumin

5/1/2025AstraZeneca Faces Escalating Legal Challenges in China Over Drug Impor...

4/30/2025Sandoz and Henlius Collaborate to Broaden Oncology Treatment Options

4/30/2025Escugen and ConjugateBio Announce Exclusive Option Agreement for EZWi-...

4/30/2025BeiGene Secures Key Patent Victory in Brukinsa Dispute with AbbVie's P...

4/29/2025AstraZeneca's China Business Recovers in Q1 2025 Amid Easing Regulator...

4/29/2025China Orders Drugmakers, Hospitals to Study US Import Replacements

4/29/2025State Council Approves Draft Medical Security Law, Strengthening Fund ...

4/29/202553 Original Research Drugs Approved in China in Early 2025

4/29/2025BeiGene's Novel Cancer Drug Sonrotoclax Seeks Approval in China

4/29/2025ConjugateBio Secures Exclusive Option for Escugen's EZWi-Fit® Platfor...

4/29/2025Europe Emerges as Key Partner for China Pharma Deals Amid US Market Sh...

4/29/2025AmCham China Reports Chinese Tariff Exemptions for Some Pharma Firms A...

4/29/2025Innovent Announces NMPA Approval of Limertinib

4/29/2025InnoCare's Orelabrutinib Receives NMPA Approval as First-Line Therapy ...

4/29/2025Hengrui Secures Approval for Hong Kong IPO

4/29/2025China NMPA Suspends Digoxin API Imports from VITAL LABS

4/29/2025China's Hospital Drug Market Shows Slight Growth in 2024, Driven by On...

4/29/2025Frontera's Gene Therapy FT-017 Achieves Dual Regulatory Clearance in U...

Page:21/57 Total number of articles:1697: [First][<<] [19] [20] [21] [22] [23] [>>] [End]